COMMUNIQUÉS West-GlobeNewswire

Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]
Alphatec Announces Participation at Stifel 2018 Healthcare Conference
31/10/2018
CARLSBAD, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
NSS Labs Announces Results of 2018 Data Center Security Gateway Group Test
31/10/2018
Three Products Receive Recommended Rating; One Product Receives Caution Rating AUSTIN, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]
Scientus Pharma Provides Update on Buccal Cannabis Development Program
31/10/2018
TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus” or the “Company”), a biopharmaceutical company conducting research and product development for extracts and formulations [...]
CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018
31/10/2018
MENLO PARK, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today [...]
OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies
31/10/2018
BATON ROUGE, La., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference
31/10/2018
RALEIGH, N.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update
31/10/2018
~ Financial Position to be Significantly Strengthened in Fourth Quarter 2018 by $145 Million of Upfront Cash and $36.7 Million Equity Investment from Separately Announced Transactions with Novo Nordisk; Company Intends [...]
Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2018 Results
31/10/2018
PORTLAND, Ore., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
31/10/2018
~ Strongbridge to Receive Upfront Payment of $145 Million and Tiered Royalty Stream from Novo Nordisk ~ ~ Novo Nordisk to Purchase Approximately 5.2 Million Ordinary Shares of Strongbridge Biopharma plc at Purchase [...]
Marrone Bio Innovations to Report Third Quarter 2018 Financial Results on Tuesday, November 13th at 4:30 p.m. Eastern Time
31/10/2018
DAVIS, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, will release financial results for [...]
Laura Clague Named to Fluidigm Board of Directors
31/10/2018
Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to [...]
Arbutus to Report Third Quarter 2018 Financial Results
31/10/2018
WARMINSTER, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third [...]
Tower One October Update
31/10/2018
VANCOUVER, British Columbia, Oct. 31, 2018 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has begun the construction of 16 towers in [...]
Director/PDMR Shareholding
31/10/2018
DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]
Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018
31/10/2018
CORAL GABLES, Fla., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Nexstim Plc: Invitation to the Extraordinary General Meeting
31/10/2018
Company announcement, Helsinki, 31 October 2018 at 2:00 PM Nexstim Plc: Invitation to the Extraordinary General Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing [...]
Nuvectra® to Participate in Two Upcoming Investor Conferences
31/10/2018
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Study: Liberals and news junkies on edge as midterms approach
31/10/2018
Left-leaning politics, frequent news consumption tied to greater anxiety symptoms SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- With the midterm elections less than a week away, anxiety in America is running high. [...]

Pages